Related Experiment Video
Updated: Nov 8, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long noncoding RNAs in intestinal homeostasis, regeneration, and cancer
Vipin K Yadav1, Amit Kumar1, Prem P Tripathi2,3
1CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, India.
Abstract:
Signaling pathways that regulate homeostasis and regeneration are found to be deregulated in various human malignancies. Accordingly, attempts have been made to target them at the protein level with little success. However, studies using high-throughput sequencing technologies suggest that only about 2% of the genome translates into proteins, whereas about 75% of the genome is transcribed into noncoding RNAs. Among noncoding RNAs, long noncoding RNAs (lncRNAs) have received tremendous attention in recent years as a crucial player in the regulation of almost all cellular processes involved in tissue homeostasis as well as in the development of various malignancies, including intestinal cancer. Emerging evidence suggests that lncRNAs play an instrumental role in the regulation of intestinal stem cells, injury-induced regeneration, and initiation and progression of intestinal tumors. Here, we summarize the recently discovered lncRNAs during intestinal homeostasis, regeneration, and tumorigenesis. We further present lncRNAs as diagnostic and therapeutic markers in intestinal pathologies.
Insights
Long noncoding RNAs (lncRNAs) are crucial regulators of intestinal homeostasis, regeneration, and cancer. These noncoding RNAs offer promising potential as diagnostic and therapeutic markers for intestinal diseases.
Area of Science:
- Molecular Biology
- Genomics
- Oncology
Background:
- Protein-level targeting of deregulated signaling pathways in human malignancies has yielded limited success.
- A significant portion of the human genome (approximately 75%) is transcribed into noncoding RNAs, with long noncoding RNAs (lncRNAs) playing critical regulatory roles.
- lncRNAs are implicated in regulating tissue homeostasis, regeneration, and the development of various cancers, including intestinal cancer.
Purpose of the Study:
- To summarize recently discovered long noncoding RNAs (lncRNAs) involved in intestinal homeostasis, regeneration, and tumorigenesis.
- To highlight the role of lncRNAs in regulating intestinal stem cells, injury-induced regeneration, and intestinal tumor initiation and progression.
- To present lncRNAs as potential diagnostic and therapeutic markers for intestinal pathologies.
Main Methods:
- Literature review of high-throughput sequencing technologies and studies on noncoding RNAs.
- Analysis of research on the function of lncRNAs in intestinal stem cell regulation, regeneration, and cancer development.
- Synthesis of current findings on lncRNAs as biomarkers in intestinal diseases.
Main Results:
- lncRNAs are key regulators of fundamental cellular processes, including tissue homeostasis and regeneration.
- Dysregulation of lncRNAs is observed in various human malignancies, particularly intestinal cancer.
- Emerging evidence points to the involvement of lncRNAs in intestinal stem cell function, regeneration after injury, and the initiation and progression of intestinal tumors.
Conclusions:
- Long noncoding RNAs (lncRNAs) are pivotal in maintaining intestinal homeostasis and orchestrating regeneration processes.
- lncRNAs represent a significant area of research for understanding and treating intestinal pathologies, including cancer.
- The diagnostic and therapeutic potential of lncRNAs in intestinal diseases warrants further investigation and development.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells
Non-LTR Retrotransposons
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

